Cogentis Therapeutics
Dr. Eitan was the first to study exosomes at the National Institute on Aging (NIA). As a pioneer in the field, Dr. Eitan has developed novel methodologies and published over 27 peer reviewed articles. During his recent tenure as senior scientist in a leading diagnostic company, Dr. Eitan has led research collaborations with several pharmaceutical companies. He currently leading the science at NeuroDex who is collaborating with us to develop a companion diagnostic for CT526.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Cogentis Therapeutics
Cogentis is committed to finding cures for a number of neurodegenerative diseases.